For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...
Advocates and clinicians say that patients are still having trouble getting refills, even though the FDA has lifted REMS for ...
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Marty Makary wouldn't commit to maintaining current access to mifepristone during his Senate confirmation hearing on Thursday ...
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
The FDA has approved an expanded indication of ... available through a restricted Risk Evaluation Management Strategy (REMS) program. The REMS requires patients to be vaccinated against ...
Dr. Marty Makary, nominee to be commissioner of the U.S. Food and Drug Administration (FDA), appears before the Senate Health ...
The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
FDA nominee Martin Makary was asked about abortion drugs, vaccine panels during a Senate hearing on his bid to lead the ...
If confirmed as FDA commissioner, Makary will report to ... which is required to be collected as a part of the REMS program, the Risk Evaluation and Mitigation Strategy,” Makary said in the ...